Oral Intake Of Yashtimadhu Sita Churna With Tandulodak In The Management Of Raktapradar

Open randomized control clinical trial of yashtimadhu sita churna with tandulodak in raktapradar with special reference to menorrhagia - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/078529

Enrollment

Registered

2024-12-24

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling Diagnostic criteria Patient Having Heavy menstruation with Duration of Bleeding More Than 7 days or Amount of Bleeding More Than 80ml or both at least Two Consecutive cycle. Patients having regular menstrual cycle. Patients having uterine fibroid size less than or equal to 4cm and fibroid measuring 4 cm only 3 fibroid will be included.Patient having HB More Than 7 gm % Included

Exclusion criteria

Exclusion criteria: 1 Patient Having Congenital Anomaly Of Reprductive System 2 Pregnant Women 3 Patients With Post Menopausal Bleeding And Intra Uterine Devices 4 Known Case Of DM Malignancy Coagulopathy 5 Uncontrolled HTN

Design outcomes

Primary

Measure	Time frame
Yashtimadhu Sita Churna With Tadulodak Is Effective In The Management Of RaktapradarTimepoint: 90 Days	—

Secondary

Measure	Time frame
Combined Oral Contraceptive Pills(Tab Ovral-L) Is Effective In The Management Of RaktapradarTimepoint: 12 Weeks	—

Countries

India

Contacts

Public ContactDr Radha Phadnis

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center Ashta

radhakulkarni6@gmail.com9545114545

Outcome results